🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Fumi Kinose

Fumi Kinose

Moffitt Cancer Center

ORCID: 0009-0009-8172-8645

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors”.

The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors

Cell chemical biology(2021)10.1016/j.chembiol.2021.07.008

N/A

1.4DataRank · unranked

38 citations

Claire E. Knezevic, Daniel S. Bejan, Yunting Luo, Xueli Li, Silvia Novakova +10 more

Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0275

N/A

0.385DataRank · unranked

12 citations

Sina Hosseinian, Mia Stroud, Emma Adhikari, James J. Saller, Matthew A. Smith +14 more

Novel Human-Derived RET Fusion NSCLC Cell Lines Have Heterogeneous Responses to RET Inhibitors and Differential Regulation of Downstream Signaling

Molecular Pharmacology(2021)10.1124/molpharm.120.000207

N/A

0.360DataRank · unranked

10 citations

Anh T. Le, Adriana Estrada‐Bernal, Andrea E. Doak, Minjae Yoo, Sarah E. Ferrara +6 more

Differential Chemoproteomics Reveals MARK2/3 as Cell Migration‐Relevant Targets of the ALK Inhibitor Brigatinib

ChemBioChem(2023)10.1002/cbic.202200766

N/A

0.292DataRank · unranked

6 citations

Yi Liao, J. Cao, Bin Fang, Sang Y. Yun, Fumi Kinose +6 more

Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3929

N/A

0.269DataRank · unranked

5 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +20 more

Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.01.514753

N/A

0DataRank · unranked

0 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +19 more